Sino Biopharmaceutical Limited
SBMFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $52 | $69 | $75 | $79 |
| - Cash | $10 | $9 | $9 | $10 |
| + Debt | $10 | $13 | $14 | $12 |
| Enterprise Value | $52 | $72 | $80 | $82 |
| Revenue | $29 | $26 | $26 | $27 |
| % Growth | 10.2% | 0.7% | -3.1% | – |
| Gross Profit | $24 | $21 | $22 | $22 |
| % Margin | 81.5% | 81% | 82.8% | 80.1% |
| EBITDA | $6 | $7 | $7 | $20 |
| % Margin | 21.2% | 26.6% | 25.7% | 74% |
| Net Income | $3 | $2 | $3 | $15 |
| % Margin | 12.1% | 8.9% | 9.8% | 54.4% |
| EPS Diluted | 0.19 | 0.1 | 0.12 | 0.73 |
| % Growth | 90.6% | -16.9% | -83.6% | – |
| Operating Cash Flow | $7 | $6 | $6 | $5 |
| Capital Expenditures | -$1 | -$2 | -$2 | -$2 |
| Free Cash Flow | $6 | $4 | $5 | $3 |